These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7662971)

  • 1. An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patients.
    Montoro JB; Oliveras J; Lorenzo JI; Tusell JM; Altisent C; Molina R; Ayestarán AI
    Blood; 1995 Sep; 86(6):2213-9. PubMed ID: 7662971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.
    Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS and hemophilia: experience in the La Paz Hemophilia Center.
    Magallón Martínez M; Ortega F; Pinilla J
    Haemostasis; 1992; 22(5):281-92. PubMed ID: 1362177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better?
    Eichinger S; Pabinger I; Kyrle PA; Köller U; Kier P; Schneider B; Lechner K
    Haemostasis; 1992; 22(1):25-31. PubMed ID: 1521824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease.
    del Amo J; Pérez-Hoyos S; Moreno A; Quintana M; Ruiz I; Cisneros JM; Ferreros I; González C; García de Olalla P; Pérez R; Hernández I
    J Acquir Immune Defic Syndr; 2006 Apr; 41(5):624-31. PubMed ID: 16652037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
    Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
    Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired immunodeficiency syndrome among patients attending hemophilia treatment centers and mortality experience of hemophiliacs in the United States.
    Johnson RE; Lawrence DN; Evatt BL; Bregman DJ; Zyla LD; Curran JW; Aledort LM; Eyster ME; Brownstein AP; Carman CJ
    Am J Epidemiol; 1985 Jun; 121(6):797-810. PubMed ID: 4014173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progression of HIV infection in a cohort of hemophiliacs over an 11-year period].
    Altisent Roca C; Ayestarán Altuna A; Tusell Puigbert JM; Oliveras Martín J; Montoro Ronsano JB; Vila Baucells M
    Med Clin (Barc); 1995 Mar; 104(11):411-4. PubMed ID: 7715259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV infection among type A and B hemophiliacs].
    Vicariot M; Fressinaud E; Fiks M; Fonlupt J; Berthier AM; Guerois C; Fimbel B
    Rev Fr Transfus Hemobiol; 1993 Oct; 36(5):417-26. PubMed ID: 8259952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
    O'Brien TR; Blattner WA; Waters D; Eyster E; Hilgartner MW; Cohen AR; Luban N; Hatzakis A; Aledort LM; Rosenberg PS; Miley WJ; Kroner BL; Goedert JJ
    JAMA; 1996 Jul; 276(2):105-10. PubMed ID: 8656501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus infection in hemophilic children.
    Jason JM; Stehr-Green J; Holman RC; Evatt BL
    Pediatrics; 1988 Oct; 82(4):565-70. PubMed ID: 3262856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
    Sabin CA; Devereux HL; Clewley G; Emery VC; Phillips AN; Loveday C; Lee CA; Griffiths PD
    J Infect Dis; 2000 May; 181(5):1800-3. PubMed ID: 10823788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.
    Sabin CA; Telfer P; Phillips AN; Bhagani S; Lee CA
    J Infect Dis; 1997 Jan; 175(1):164-8. PubMed ID: 8985212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.
    Duesberg PH
    Genetica; 1995; 95(1-3):51-70. PubMed ID: 7744263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.
    Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA
    Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients.
    Roosendaal G; van der Schouw Y; Mauser-Bunschoten E; Borleffs J; van den Berg H
    Vox Sang; 1998; 75(4):261-6. PubMed ID: 9873260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.
    Gjerset GF; Pike MC; Mosley JW; Hassett J; Fletcher MA; Donegan E; Parker JW; Counts RB; Zhou Y; Kasper CK
    Blood; 1994 Sep; 84(5):1666-71. PubMed ID: 7915149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race, sex, drug use, and progression of human immunodeficiency virus disease.
    Chaisson RE; Keruly JC; Moore RD
    N Engl J Med; 1995 Sep; 333(12):751-6. PubMed ID: 7643881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus.
    Diamondstone LS; Blakley SA; Rice JC; Clark RA; Goedert JJ
    Am J Epidemiol; 1995 Aug; 142(3):304-13. PubMed ID: 7631634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.